BeOne Medicines (ONC) Work In Process (2024 - 2026)

BeOne Medicines (ONC) has 3 years of Work In Process data on file, last reported at $109.2 million in Q1 2026.

• Quarterly Work In Process changed N/A year-over-year to $109.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $109.2 million (changed N/A YoY) and the FY2025 annual result came in at $122.7 million, up 104.07% from the prior year.
• Work In Process eased to $109.2 million in Q1 2026 per ONC's latest filing, from $122.7 million in the prior quarter.
• Across five years, Work In Process topped out at $122.7 million in Q4 2025 and bottomed at $60.1 million in Q4 2024.
• The 3-year median for Work In Process is $109.2 million (2026), against an average of $97.3 million.
• Peak annual rise in Work In Process reached 104.07% in 2025, while the deepest fall reached 104.07% in 2025.
• Tracing ONC's Work In Process over 3 years: stood at $60.1 million in 2024, then jumped by 104.07% to $122.7 million in 2025, then dropped by 10.98% to $109.2 million in 2026.
• Per Business Quant, the three latest ONC Work In Process figures stand at $109.2 million (Q1 2026), $122.7 million (Q4 2025), and $60.1 million (Q4 2024).

Peer Comparison